NCT06498622 2024-07-12Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With EnvafolimabAnhui Provincial HospitalPhase 2 Recruiting45 enrolled
NCT06321081 2024-03-20ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCBeijing HospitalPhase 2 Recruiting60 enrolled